Stock TYCHE6 TYCHE INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tyche Industries Limited

Equities

TYCHE6

INE443B01012

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 05:58:27 26/06/2024 BST 		5-day change 1st Jan Change
177 INR -0.45% Intraday chart for Tyche Industries Limited -0.56% -4.84%
05-28 Tyche Industries Limited Recommends Final Dividend CI
05-28 Tyche Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 1,098 706.9 767.4 1,746 1,415 1,430
Enterprise Value (EV) 1 842.4 414.3 320.7 1,150 757.5 704.4
P/E ratio 18.8 x 9.9 x 4.37 x 8.74 x 15.2 x 10.1 x
Yield 0.47% 0.72% 1.34% 0.59% 1.09% 1.43%
Capitalization / Revenue 2.13 x 1.31 x 1.03 x 2.2 x 2.25 x 1.89 x
EV / Revenue 1.63 x 0.77 x 0.43 x 1.45 x 1.2 x 0.93 x
EV / EBITDA 9.23 x 4.44 x 1.46 x 4.44 x 6.47 x 4.3 x
EV / FCF 26.4 x 20.8 x 2.82 x 10.5 x 21.4 x 22 x
FCF Yield 3.78% 4.8% 35.4% 9.55% 4.67% 4.54%
Price to Book 2.07 x 1.17 x 0.99 x 1.82 x 1.36 x 1.23 x
Nbr of stocks (in thousands) 10,231 10,245 10,245 10,245 10,245 10,245
Reference price 2 107.3 69.00 74.90 170.4 138.2 139.6
Announcement Date 30/05/18 05/09/19 07/09/20 07/09/21 06/09/22 01/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 516 541 742.7 794 630.2 756
EBITDA 1 91.24 93.27 219.6 258.8 117.1 163.7
EBIT 1 72.78 74.86 202.2 241.5 99.23 145.9
Operating Margin 14.11% 13.84% 27.23% 30.42% 15.75% 19.3%
Earnings before Tax (EBT) 1 88.65 98.46 233.3 267.3 126.4 190.8
Net income 1 58.63 71.46 175.6 199.8 93.31 141.7
Net margin 11.36% 13.21% 23.64% 25.17% 14.81% 18.75%
EPS 2 5.720 6.970 17.14 19.51 9.108 13.83
Free Cash Flow 1 31.85 19.89 113.6 109.8 35.38 31.95
FCF margin 6.17% 3.68% 15.29% 13.83% 5.61% 4.23%
FCF Conversion (EBITDA) 34.91% 21.32% 51.71% 42.43% 30.21% 19.53%
FCF Conversion (Net income) 54.33% 27.83% 64.67% 54.94% 37.92% 22.55%
Dividend per Share 2 0.5000 0.5000 1.000 1.000 1.500 2.000
Announcement Date 30/05/18 05/09/19 07/09/20 07/09/21 06/09/22 01/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 255 293 447 596 658 726
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 31.9 19.9 114 110 35.4 32
ROE (net income / shareholders' equity) 11.6% 12.6% 25.6% 23.1% 9.32% 12.8%
ROA (Net income/ Total Assets) 7.14% 6.65% 15% 14.3% 5.23% 6.98%
Assets 1 821.5 1,075 1,172 1,401 1,785 2,031
Book Value Per Share 2 51.90 58.80 75.30 93.70 102.0 114.0
Cash Flow per Share 2 25.10 28.60 2.310 7.120 3.510 6.560
Capex 1 14.2 11.8 2.77 25.1 9.91 17.5
Capex / Sales 2.76% 2.19% 0.37% 3.16% 1.57% 2.32%
Announcement Date 30/05/18 05/09/19 07/09/20 07/09/21 06/09/22 01/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
TYCHE INDUSTRIES LIMITED Stock Tyche Industries Limited
-4.84% 21.83M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.19% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+47.26% 654B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.09% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+21.92% 337B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.40% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+3.64% 229B
NOVARTIS AG Stock Novartis AG
+12.98% 219B
AMGEN INC. Stock Amgen Inc.
+10.86% 171B
PFIZER, INC. Stock Pfizer, Inc.
-2.78% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TYCHE6 Stock
  4. Financials Tyche Industries Limited